The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial launch generated massive profits, the end of its intellectual property protection opened the door to off-brand competitors, dramatically eroding sales. This presents a unique challenge for drug manufacturers relying on similar blockbuster prod

The story of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in sales , its patent expiration created a wave of knock-off medications, significantly impacting its market share . While certain businesses may try to capitalize on similar conditions , the existing